KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Jazz Pharmaceuticals (JAZZ) Return on Assets (2016 - 2025)

Jazz Pharmaceuticals has reported Return on Assets over the past 15 years, most recently at 0.02% for Q4 2025.

  • Quarterly results put Return on Assets at 0.02% for Q4 2025, down 7.0% from a year ago — trailing twelve months through Dec 2025 was 0.02% (down 7.0% YoY), and the annual figure for FY2025 was 0.03%, down 8.0%.
  • Return on Assets for Q4 2025 was 0.02% at Jazz Pharmaceuticals, up from 0.02% in the prior quarter.
  • Over the last five years, Return on Assets for JAZZ hit a ceiling of 0.08% in Q1 2021 and a floor of 0.04% in Q1 2022.
  • Median Return on Assets over the past 5 years was 0.0% (2022), compared with a mean of 0.01%.
  • Biggest five-year swings in Return on Assets: decreased -11bps in 2022 and later increased 6bps in 2023.
  • Jazz Pharmaceuticals' Return on Assets stood at 0.03% in 2021, then increased by 24bps to 0.02% in 2022, then skyrocketed by 283bps to 0.04% in 2023, then increased by 25bps to 0.05% in 2024, then tumbled by -149bps to 0.02% in 2025.
  • The last three reported values for Return on Assets were 0.02% (Q4 2025), 0.02% (Q3 2025), and 0.03% (Q2 2025) per Business Quant data.